Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) Stock Price
HLNStock
$10.13+6.81%52W
Market Cap$44.55B
P/E19.77x
PEG Ratio2.33
Div yield1.26%
Beta0.70
HLN Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-3.67%
Price vs S&P 500 (4W)10.75%
PEG Ratio2.33
VGM Score59.85
P/E Ratio (Annual)19.77x
Indicated Dividend Yield (Annual)1.26%
HLN Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.96
3.96
3.96
3.92
Industry Peers — Cosmetics & Toiletries(22)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|---|---|---|
HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares) | C | C | B | 3.0x | 1.2% | 65.5% | 8.3% | $10.13 |
| CLColgate-Palmolive Company | C | C | B | 3.6x | 5.2% | 60.4% | -3.5% | $94.11 |
| ELThe Estee Lauder Companies Inc. Class A | D | D | A | 2.5x | 5.1% | 75.5% | -42.3% | $104.54 |
| KVUEKenvue Inc. | C | C | A | 2.4x | 1.8% | 58.6% | — | $18.91 |
| ELFe.l.f. Beauty, Inc. | D | B | A | 3.8x | 31.2% | 74.4% | 30.1% | $113.54 |
| IPARInterparfums, Inc. Common Stock | C | B | B | 2.5x | 2.9% | 55.8% | 34.2% | $115.69 |
| COTYCOTY INC | B | C | B | 0.5x | -1.5% | 62.9% | — | $3.20 |
| EPCEdgewell Personal Care Company | B | D | B | 0.6x | -7.0% | 41.1% | -15.5% | $27.91 |
| ODDODDITY Tech Ltd. Class A Ordinary Shares | C | C | B | 1.5x | -9.7% | 70.0% | 50.4% | $22.43 |
| YSGYatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | A | C | C | 0.4x | -1.6% | 77.4% | — | $2.58 |
| PTNMPitanium Limited Class A Ordinary shares | — | — | B | — | — | — | — | $10.39 |
About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
Haleon is a leading global consumer health company operating across oral care, digestive health, pain relief, and nutrition. The company generates 60% of revenue from global power brands—Sensodyne, Advil, Centrum, and Poligrip—which hold leading positions in their categories, supplemented by regional brands including Emergen-C, Eno, Tums, and Caltrate. Formed by combining consumer health divisions from GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022.